Peripheral arterial disease in diabetes mellitus type 1 and type 2: are there different risk factors?
PAD risk factors and micro- and macrovascular comorbidity are very similar in type 1 and type 2 diabetes.
We conclude that intravenous pamidronate is a good alternative for oral bisphosphonates in the treatment of osteoporosis in patients with contraindications or intolerance during treatment with oral bisphosphonates.